HKDC1 and familial pancreatic carcinoma: HKDC1 is identified as a promising biomarker for early cancer diagnosis, with significantly elevated expression across multiple malignancies, including gastric, lung, hepatocellular, and pancreatic cancers, correlating with tumor growth and glycolytic activity.